When is catheter removal indicated for a gram‑negative bacillus catheter‑related bloodstream infection (CRBSI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Catheter Removal for Gram-Negative Bacillus CRBSI

For gram-negative bacillus catheter-related bloodstream infection, remove short-term catheters immediately in all cases, and remove long-term catheters if the patient has severe sepsis, persistent bacteremia beyond 72 hours despite appropriate antibiotics, or infection with high-risk organisms like Pseudomonas aeruginosa. 1

Short-Term Central Venous Catheters (Non-Tunneled CVCs)

Immediate removal is mandatory for all gram-negative bacillus CRBSI involving short-term catheters. 1

  • The IDSA guidelines provide a strong recommendation (A-II) that short-term catheters must be removed when gram-negative bacilli are isolated from blood cultures. 1
  • Most gram-negative organisms causing CRBSI are non-enteric hospital-acquired pathogens (Stenotrophomonas maltophilia, Pseudomonas spp., Acinetobacter spp.) that form biofilms resistant to systemic antibiotics alone. 2
  • Early catheter removal (within 72 hours) prevents relapse rates, which can reach 6.4% even with appropriate antibiotics if the catheter remains. 3
  • Do not attempt guidewire exchange—place the new catheter at a completely different anatomical site to avoid reinfecting the same tract. 4

Long-Term Catheters (Tunneled, PICCs, Hemodialysis Catheters)

Remove the catheter if any of the following are present:

Absolute Indications for Removal

  • Severe sepsis or septic shock at presentation 1, 2, 5
  • Persistent bacteremia or fever >72 hours after initiating appropriate antimicrobial therapy to which the organism is susceptible 1
  • Complicated infection: endocarditis, suppurative thrombophlebitis, metastatic abscess, or osteomyelitis 1
  • High-risk organisms: Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Acinetobacter spp., or other non-enteric gram-negative bacilli 1, 2, 3

Catheter Retention May Be Attempted (With Caution)

Only consider retention if ALL of the following criteria are met:

  • Uncomplicated infection (no severe sepsis, no metastatic foci) 1
  • Blood cultures clear within 72 hours of appropriate antibiotics 1
  • The organism is a less virulent enteric gram-negative bacillus (e.g., E. coli, Klebsiella spp.) rather than Pseudomonas or other high-risk pathogens 2, 3
  • The patient has limited alternative venous access (e.g., hemodialysis-dependent, short-gut syndrome requiring long-term TPN) 1
  • Antibiotic lock therapy is used in addition to systemic antibiotics 1

Critical caveat: Catheter retention was the only independent risk factor strongly associated with relapse (OR 145.32,95% CI 12.66–1667.37) in a 2020 study of gram-negative CRBSI. 3 Even with antibiotic lock therapy, failure rates remain substantial, and retention should be reserved for patients with no other access options. 2, 6

Empirical Antibiotic Coverage

While awaiting culture results, empirical therapy must cover gram-negative bacilli in the following high-risk scenarios:

  • Critically ill patients or those with sepsis 1, 5
  • Neutropenic patients (absolute neutrophil count <500/μL) 1, 5
  • Femoral catheter in place 1
  • Known colonization with multidrug-resistant gram-negative organisms 1
  • Recent antibiotic exposure within 30 days 5
  • Peripheral vascular disease 5

Recommended empirical regimens (select based on local antibiogram and severity): 1

  • Fourth-generation cephalosporin (cefepime)
  • Carbapenem (meropenem, imipenem)
  • β-lactam/β-lactamase inhibitor (piperacillin-tazobactam)
  • Add a second agent from a different class (e.g., aminoglycoside or fluoroquinolone) if the patient is critically ill or has known MDR colonization, then de-escalate once susceptibilities return 1

Antibiotic Duration After Catheter Removal

  • Uncomplicated infection with catheter removal: 7–14 days of systemic antibiotics 1, 3
  • Persistent bacteremia >72 hours after removal or metastatic complications: extend therapy to 4–6 weeks based on the site of metastatic infection 1
  • A 2020 prospective pilot study demonstrated that 7 days of antibiotics after catheter removal was safe and effective in low-risk patients without relapse. 3

Follow-Up and Surveillance

  • Obtain repeat blood cultures 2–3 days after initiating therapy to document clearance of bacteremia. 1, 4
  • If bacteremia persists beyond 72 hours, remove the catheter immediately (if not already done) and evaluate for endocarditis, suppurative thrombophlebitis, or other metastatic foci. 1
  • Do not place a new long-term catheter until blood cultures are documented negative, typically requiring 2–3 days of appropriate antibiotics. 4

Common Pitfalls to Avoid

  • Do not rely on antibiotic lock therapy alone for gram-negative CRBSI—it has limited efficacy against biofilm-producing organisms and should only be used as an adjunct to systemic therapy in retained catheters. 1
  • Do not perform guidewire exchange for infected catheters—this leaves the infected subcutaneous tract intact and increases treatment failure. 4
  • Do not delay catheter removal in patients with Pseudomonas or other high-risk gram-negative organisms—early removal (<72 hours) is essential to prevent relapse and metastatic complications. 2, 3
  • Do not assume normal ultrasound rules out CRBSI—one-third of pediatric patients with confirmed CRBSI had no abnormal sonographic findings, so clinical judgment and culture results take precedence. 7

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.